Stockscreener 앱 받기
11.92
7.93%
0.82
전일 마감가:
$11.10
열려 있는:
$11.22
하루 거래량:
358.40K
Relative Volume:
0.26
시가총액:
$94.35M
수익:
$49.09M
순이익/손실:
$-52.15M
주가수익비율:
-18.34
EPS:
-0.65
순현금흐름:
$-45.93M
1주 성능:
+52.03%
1개월 성능:
+77.48%
6개월 성능:
+41.01%
1년 성능:
-33.48%
1일 변동 폭
$11.16
$12.46
1주일 범위
$7.65
$12.46
52주 변동 폭
$3.436
$21.80
바이오데식스 Stock (BDSX) Company Profile
명칭
Biodesix Inc
전화
303-417-0500
주소
919 WEST DILLON ROAD, LOUISVILLE
BDSX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
11.86 | 88.31M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
626.84 | 240.25B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
234.43 | 169.58B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
696.14 | 55.18B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
235.10 | 40.71B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
134.94 | 39.30B | 6.95B | 1.30B | 1.15B | 4.5696 |
바이오데식스 Stock (BDSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-14 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-09-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-07-26 | 개시 | Craig Hallum | Buy |
| 2024-05-13 | 개시 | TD Cowen | Buy |
| 2024-05-03 | 개시 | Lake Street | Buy |
| 2021-11-17 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-23 | 개시 | BTIG Research | Buy |
| 2020-11-23 | 개시 | Canaccord Genuity | Buy |
| 2020-11-23 | 개시 | Morgan Stanley | Overweight |
| 2020-11-23 | 개시 | William Blair | Outperform |
모두보기
바이오데식스 주식(BDSX)의 최신 뉴스
How geopolitical tensions affect Biodesix Inc. stockWeekly Trade Review & High Accuracy Investment Entry Signals - bollywoodhelpline.com
BDSX stock shot up 23% pre-market today — what’s fueling the surge? - MSN
Biodesix Inc. (BDSX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Biodesix, Inc. (NASDAQ:BDSX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Investors Still Aren't Entirely Convinced By Biodesix, Inc.'s (NASDAQ:BDSX) Revenues Despite 26% Price Jump - Sahm
BDSX Stock Price, Forecast & Analysis | BIODESIX INC (NASDAQ:BDSX) - Chartmill
Biodesix stock soars as preliminary results exceed guidance, achieves EBITDA profitability - Investing.com Nigeria
Quarterly Trades: Will Biodesix Inc stock rally after Fed decisions2025 Market Overview & Growth Focused Entry Point Reports - Bộ Nội Vụ
Biodesix: Strengthening Fundamentals, Emerging Profitability, and Strategic Growth Support Buy Rating and $20 Price Target - TipRanks
Biodesix: Strong Operational Momentum but Ongoing Capital Concerns Justify Hold Rating - TipRanks
Biodesix reports 41% revenue growth in Q4, exceeds 2025 guidance By Investing.com - Investing.com Nigeria
Biodesix sees stock soar after surpassing sales guidance - BizWest
BDSX Faces Financial Hurdles as Stock Volatility Heightens - StocksToTrade
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Biodesix Shares Rocket 42% on Record FY2025 Results and Path to Profitability - FinancialContent
BDSX Stock Shot Up 23% Pre-Market Today — What’s Fueling The Surge? - Asianet Newsable
Biodesix Stock Rebounds on Strategic Plans for Market Expansion - timothysykes.com
This Diagnostics Stock Is Surging 23% Pre-Market Today – Here’s Why - Stocktwits
Biodesix (BDSX) Surges 41% on Strong Preliminary Q4 and FY Resul - GuruFocus
Biodesix Surges On Strong Preliminary Q4 And FY2025 Revenue Results - Nasdaq
Biodesix skyrockets 43%, expects FY revenue to beat guidance - MSN
Biodesix (BDSX) Surpasses 2025 Revenue Expectations with Strong Q4 Performance - GuruFocus
Biodesix reports 41% revenue growth in Q4, exceeds 2025 guidance - Investing.com
Biodesix, Inc. Reports Estimated Q4 2025 Revenue of $28.8 Million, Achieving 41% Growth and Full-Year Revenue of $88.5 Million, Up 24% - Quiver Quantitative
Biodesix prelim Q4 revenue beats expectations, helped by growth in Lung Diagnostics - TradingView — Track All Markets
Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited) - bdtonline.com
Biodesix, Inc. Provides Earnings Guidance for the Fourth Quarter Ended December 31, 2025 - marketscreener.com
Wall Street Analysts Believe Biodesix (BDSX) Could Rally 325.67%: Here's is How to Trade - MSN
Is Biodesix Inc. stock affected by interest rate hikesWeekly Investment Summary & Daily Chart Pattern Signals - Улправда
What dividend safety score for Biodesix Inc. stockDurability and Wear Notes & HOKA model picks for your routine - ulpravda.ru
Will Biodesix Inc. stock split again soonTreasury Yields & Capital Efficiency Focused Ideas - ulpravda.ru
Will Biodesix Inc. stock benefit from automationMarket Risk Report & Fast Exit/Entry Strategy Plans - Улправда
BDSX stock touches 52-week low at $1 amid market challenges - MSN
Fundamentals Check: Why analysts recommend Modine Manufacturing Company MMF stockJuly 2025 Market Mood & Free Real-Time Market Sentiment Alerts - moha.gov.vn
Biodesix Jumps 46% As Insider Buying, Retail Optimism Offset Scotiabank Target Cut - MSN
Biodesix CFO sells $22,794 in stock - MSN
BDSX Stock Rises After Publication of Study Data for Nodify CDT Test - MSN
Biodesix, Inc. at Risk: How a Federal Shutdown Could Disrupt Revenue and Growth - MSN
Options Flow: What dividend safety score for Biodesix Inc stock2025 Top Decliners & Low Risk High Win Rate Picks - moha.gov.vn
Analyst Calls: Why analysts upgrade Biodesix Inc stock2025 Price Action Summary & Growth Focused Entry Reports - moha.gov.vn
Biodesix, Inc. (NASDAQ:BDSX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Q4 2024 Earnings Call Transcript - MSN
Is Biodesix Inc. stock attractive for retirement portfoliosGap Down & Safe Capital Growth Stock Tips - Улправда
Why Biodesix Inc. stock is considered a top pick2025 Valuation Update & Precise Trade Entry Recommendations - DonanımHaber
바이오데식스 (BDSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.79%
0.40%
자본화:
|
볼륨(24시간):